Date	Chamber	Action
1/13/2021	House	Session Sine Die

Statutes Amended In Order of Appearance

720 ILCS 570/315.7 new

Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression to a patient when one or more of the following conditions are present: (1) the prescription dosage for the patient is 90 or more morphine milligram equivalents of an opioid medication per day; (2) an opioid medication is prescribed concurrently with a prescription for benzodiazepine; (3) the patient presents with an increased risk for overdose, including a patient with a history of overdose, a patient with a history of substance use disorder, or a patient at risk for returning to a high dose of opioid medication to which the patient is no longer tolerant. Provides other requirements and exemptions. Makes other changes. Effective January 1, 2020.

Actions 

Date	Chamber	Action
2/14/2019	House	Filed with the Clerk by Rep. Marcus C. Evans, Jr.
2/14/2019	House	First Reading
2/14/2019	House	Referred to Rules Committee
2/26/2019	House	Assigned to Prescription Drug Affordability & Accessibility Committee
3/19/2019	House	House Committee Amendment No. 1 Filed with Clerk by Rep. Marcus C. Evans, Jr.
3/19/2019	House	House Committee Amendment No. 1 Referred to Rules Committee
3/19/2019	House	Added Co-Sponsor Rep. Robyn Gabel
3/20/2019	House	House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
3/21/2019	House	Added Co-Sponsor Rep. Katie Stuart
3/28/2019	House	Added Co-Sponsor Rep. Michelle Mussman
3/29/2019	House	Rule 19(a) / Re-referred to Rules Committee
3/29/2019	House	House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
1/13/2021	House	Session Sine Die

Back To Top